MVIS US Listed Biotech 25 Index

The MVIS US Listed Biotech 25 Index (MVBBH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the biotech industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from biotech related products and services, such as research and development, production, or marketing and sales of drugs based on genetic analysis and diagnostic equipment.

Index Parameters

Market Capitalisation values are updated daily.

Launch Date: 12 Aug 2011
Calculator: Solactive AG
Dissemination: Realtime
Dissemination Period: 09:30 - 16:30 (EST)
Type: Sector
Currency: USD
Current Components: 25
Base Date: 29 Sep 2000
Base Value: 1000
Full Market Cap: 795.25 bn USD
Free-Float Market Cap: 529.81 bn USD
Next Review: 18 Mar 2022

Identifiers

PriceTotal Return NetTotal Return Gross
ISIN:DE000SLA0LB8DE000SLA0LM5DE000SLA1CF6
Sedol:B68L4M6B4QZQM0B8J7XY2
WKN:SLA0LBSLA0LMSLA1CF
Bloomberg:MVBBH MVBBHTR MVBBHTRG
Reuters:.MVBBH.MVBBHTR.MVBBHTRG
Telekurs:136244111362441220729403
FIGI:BBG001YHPL71BBG001YHPL80BBG00440CW39

Non-Dissemination Days

Following the index methodology as described in the MVIS Global Equity Index Guide, the Index will not be disseminated on the following days:

  • 17 Jan 2022
  • 21 Feb 2022
  • 15 Apr 2022
  • 30 May 2022
  • 20 Jun 2022
  • 04 Jul 2022
  • 05 Sep 2022
  • 24 Nov 2022
  • 26 Dec 2022
Up